OMI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Owens & Minor, Inc.

Owens & Minor, Inc. is a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services to deliver significant and sustained value across the breadth of the industry – from acute care to patients in their home. Aligned to its Mission of Empowering Its Customers to Advance HealthcareTM, more than 15,000 global teammates serve over 4,000 healthcare industry customers. A vertically-integrated, predominantly Americas-based footprint enables Owens & Minor to reliably supply its self-manufactured surgical and PPE products. This seamless value chain integrates with a portfolio of products representing 1,200 branded suppliers. Operating continuously since 1882 from its headquarters in Richmond, Virginia, Owens & Minor has grown into a FORTUNE 500 company with operations located across North America, Asia, Europe and Latin America.
CEO
Edward Pesicka
Employees
18800
Headquarters

9120 Lockwood Blvd
Mechanicsville, Virginia 23116-2015
Phone: 18047237000
www.owens-minor.com

News

5 Stocks Loved by Brokers Worth Watching Currently
Aug 05, 2024 18:45pm

After spiking in the first quarter of 2024, inflation has been weakening from April. In fact, per the June data, the annual rate of inflation dropped to its lowest level in more than two years, raising hopes of a rate cut in September. This bodes well as low interest rates improve consumer outlays, decrease the cost of borrowings and, in turn, boost economic growth. Additionally, second-quarter quarter earnings have been impressive so far, with many companies reporting better-than-expected earnings per share. Given this brightening scenario, investors would like to design a winning portfolio of stocks for impressive returns. One way to do so is by following broker advice. Stocks like ADTRAN (NASDAQ: ADTN ), Bread Financial (NYSE: BFH ), Owens & Minor (NYSE: OMI ), Bally''s Corporation (NYSE: BALY ) and AMC Networks (NASDAQ: AMCX ) are worth monitoring. We have designed a screen to shortlist stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks.


Source:Benzinga
Owens & Minor, Inc. (OMI) Q2 2024 Earnings Call Transcript
Aug 02, 2024 16:13pm

Owens & Minor, Inc. (NYSE:NYSE:OMI) Q2 2024 Earnings Conference Call August 2, 2024 8:30 AM ETCompany ParticipantsJackie Marcus - IREd Pesicka - CEOJon…


Source:Seeking Alpha
OMI Stock Earnings: Owens & Minor Beats EPS, Beats Revenue for Q2 2024
Aug 02, 2024 14:53pm

Owens & Minor (NYSE: OMI ) just reported results for the second quarter of 2024. Owens & Minor reported earnings per share of 36 cents. This was above the analyst estimate for EPS of 31 cents. The company reported revenue of $2.67 billion. This was 1.02% better than the analyst estimate for revenue of $2.64 billion. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected]. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post OMI Stock Earnings: Owens & Minor Beats EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace .


Source:InvestorPlace
Healthcare Logistics Provider Owens & Minor Calls Q2 Performance Consistent With Expectations, Reiterates Annual Guidance
Aug 02, 2024 12:54pm

On Friday, Owens & Minor Inc. (NYSE: OMI ) reported that the second quarter of 2024 adjusted EPS of $0.36, double the $0.18 reported a year ago, beating the consensus of $0.33 . The company reported sales of $2.671 billion, up 4% year-over-year, almost in line with the consensus of $2.646 billion . Patient Direct revenue of $660 million, up 4% compared to the second quarter of 2023, driven by continued strong growth in diabetes and sleep supplies. Related: Healthcare Logistics Service Firm Owens & Minor To Buy Home-Based Care Equipment Firm For $1.4B, Sees … Full story available on Benzinga.com


Source:Benzinga
Owens & Minor Releases Earnings Details on Website
Aug 02, 2024 10:58am

Owens & Minor (OMI) has provided an update. On August 2, 2024, the Company made its earnings presentation available to the public via the Investor …


Source:TipRanks
Owens & Minor beats top-line and bottom-line estimates; reaffirms FY24 outlook
Aug 02, 2024 10:38am

No summary available.


Source:Seeking Alpha
Owens & Minor Reports Second Quarter 2024 Financial Results
Aug 02, 2024 10:30am

Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2024. Key Highlights: Consolidated revenue of $2.7 billion in the second quarter, representing year-over-year growth of 4% Net loss of $(32) million or $(0.42) per share in the second quarter Adjusted EBITDA of $127 million in the second quarter, representing year-over-year growth Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Owens & Minor Reports Second Quarter 2024 Financial Results | OMI Stock News
Aug 02, 2024 10:30am

Owens & Minor Q2 results: Revenue up 4%, adjusted EPS doubles. Despite net loss, strong cash flow enables debt reduction. Learn about the healthcare company''s performance and strategic acquisition.


Source:Stock Titan
Owens & Minor Q2 2024 Earnings Preview
Aug 01, 2024 15:50pm

No summary available.


Source:Seeking Alpha
OMI Investors Have Opportunity to Join Owens & Minor, Inc. Fraud Investigation with the Schall Law Firm
Aug 01, 2024 13:52pm

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Owens & Minor, Inc. (“Owens & Minor” or “the Company”) (NYSE: OMI) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online